World Journal of Urology

, Volume 31, Issue 1, pp 1–3

Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms

Topic paper


  1. 1.
    Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27:289–293CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241CrossRefPubMedGoogle Scholar
  3. 3.
    Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29CrossRefPubMedGoogle Scholar
  4. 4.
    Harris AL, Neal DE (1992) Bladder cancer–field versus clonal origin. N Engl J Med 326:759–761CrossRefPubMedGoogle Scholar
  5. 5.
    Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B (1992) Clonal origin bladder cancer. N Engl J Med 326:737–740CrossRefPubMedGoogle Scholar
  6. 6.
    Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N et al (2005) Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23:2903–2910CrossRefPubMedGoogle Scholar
  7. 7.
    Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M et al (2007) Behavior of urothelial carcinoma with respect to anatomical location. J Urol 177:1715–1720CrossRefPubMedGoogle Scholar
  8. 8.
    Roupret M, Azzouzi AR, Cussenot O (2005) Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int 96:489–492CrossRefPubMedGoogle Scholar
  9. 9.
    Roupret M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol 54:1226–1236CrossRefPubMedGoogle Scholar
  10. 10.
    Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA et al (2012) A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. BJU Int. doi:10.1111/j.1464-410X.2012.11298.x.
  11. 11.
    Roupret M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC et al (2005) Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 65:1233–1237CrossRefPubMedGoogle Scholar
  12. 12.
    Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104:1436–1440CrossRefPubMedGoogle Scholar
  13. 13.
    Laing C, Hamour S, Sheaff M, Miller R, Woolfson R (2006) Chinese herbal uropathy and nephropathy. Lancet 368:338CrossRefPubMedGoogle Scholar
  14. 14.
    Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M et al (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342:1686–1692CrossRefPubMedGoogle Scholar
  15. 15.
    Roupret M, Cancel-Tassin G, Comperat E, Fromont G, Sibony M, Molinie V et al (2007) Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. Cancer Epidemiol Biomarkers Prev 16:2500–2503CrossRefPubMedGoogle Scholar
  16. 16.
    Roupret M, Drouin SJ, Cancel-Tassin G, Comperat E, Larre S, Cussenot O (2012) Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis. J Urol 187:424–428CrossRefPubMedGoogle Scholar
  17. 17.
    Cornu JN, Roupret M, Carpentier X, Geavlete B, de Medina SG, Cussenot O et al (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28:151–156CrossRefPubMedGoogle Scholar
  18. 18.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM et al (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int. doi:10.1111/j.1464-410X.2012.10960.x.
  19. 19.
    Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R et al (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184:453–458CrossRefPubMedGoogle Scholar
  20. 20.
    Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W et al (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 29(4):481–486Google Scholar
  21. 21.
    Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105(3):300–308Google Scholar
  22. 22.
    Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27:612–618CrossRefPubMedGoogle Scholar
  23. 23.
    Yates DR, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long JA et al (2012) Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer 106:1083–1088CrossRefPubMedGoogle Scholar
  24. 24.
    Ariane MM, Colin P, Ouzzane A, Pignot G, Audouin M, Cornu JN et al (2012) Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol 19:301–308CrossRefPubMedGoogle Scholar
  25. 25.
    Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R et al (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584–594CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Academic Department of Urology of Pitié-Salpétrière, Assistance-Publique Hôpitaux de Paris, Faculté de Médecine Pierre et Marie Curie, Hopital PitiéUniversity Paris 6ParisFrance
  2. 2.Academic Department of UrologyCHRU Lille, University Lille Nord de FranceLilleFrance

Personalised recommendations